Tissue factors and venous thromboembolism in cancer patients.
10.3785/j.issn.1008-9292.2020.12.13
- Author:
Huiqi ZHU
1
;
Kejing YING
1
Author Information
1. Department of Respiratory Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, National Regional Medical Center for Respiratory Diseases, Hangzhou 310016, China.
- Publication Type:Journal Article
- Keywords:
Neoplasm metastasis;
Prediction;
Review;
Tissue factors;
Tumor therapy;
Venous thromboembolism
- MeSH:
Humans;
Neoplasms/complications*;
Risk Factors;
Thromboplastin/metabolism*;
Thrombosis;
Venous Thromboembolism/physiopathology*
- From:
Journal of Zhejiang University. Medical sciences
2020;49(6):772-778
- CountryChina
- Language:Chinese
-
Abstract:
Malignant tumor is one of the important acquired risk factors of venous thromboembolism (VTE). As the transmembrane receptor of coagulation factor Ⅶ and activated coagulation factor Ⅶa
